Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 5-6/2021

17.12.2020 | review article

Prevalence of neuropathy in patients with type 2 diabetes in Iran

A systematic review and meta-analysis

verfasst von: MD Dariush Afshari Aliabadi, MD Nasrin Moradian, MSc Elham Rahmanian, MSc Masoud Mohammadi

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 5-6/2021

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Diabetic neuropathy is one of the most common complications of diabetes, which leads to amputation and significant disability in patients. Studies conducted in this field show different prevalences and inconsistencies in the country. This study attempts to determine the overall prevalence of neuropathy in patients with type 2 diabetes in Iran with a meta-analysis.

Methods

The present study was conducted using a meta-analysis method from January 2000 to December 2018. The papers related to the study subject were obtained from searching Scopus, ScienceDirect, Magiran, Barakat Knowledge Network, SID, Medline (PubMed), and Google Scholar databases. The heterogeneity of studies was examined using I2 index and the data were analyzed using the software Comprehensive Meta-Analysis (version 3, Biostat, Englewood, NJ, USA).

Results

The results of the systematic review showed regional differences in the prevalence of neuropathy in Iran. According to the meta-analysis and review of 10 studies and 2992 individuals between the ages of 5 years and 86 years, the overall prevalence of neuropathy in type 2 diabetes patients in Iran was 56.5% (95% confidence interval, CI 42.8–69.3%). The highest prevalence of neuropathy in type 2 diabetic patients was found in Mashhad with 87.2% (95% CI 77.9–92.3%) in 2012 and the lowest prevalence of neuropathy in type 2 diabetic patients was found in Ahvaz with 22.7% (95% CI 18.5–27.6%) in 2014. With the increase in years of research, the prevalence of neuropathy in type 2 diabetes in Iran was reduced, with statistically significant differences (P < 0.05).

Conclusion

Considering the high prevalence of neuropathy in patients with type 2 diabetes in the country, it is essential that health policy makers take effective measures to reduce this disease in diabetes patients.

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Literatur
1.
Zurück zum Zitat Pradeepa R, Mohan V. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation. Eur J Clin Nutr. 2017;71(7):816–24. CrossRef Pradeepa R, Mohan V. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation. Eur J Clin Nutr. 2017;71(7):816–24. CrossRef
2.
Zurück zum Zitat Khatib O, Tabatabaei Malazy O. Prevention and public approach to diabetic foot. Iran J Diabetes Lipid Disord. 2007;7(2):123–33. Khatib O, Tabatabaei Malazy O. Prevention and public approach to diabetic foot. Iran J Diabetes Lipid Disord. 2007;7(2):123–33.
3.
Zurück zum Zitat Chen DK, Frizzi KE, Guernsey LS, Ladt K, Mizisin AP, Calcutt NA. Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheralneuropathy in type‑1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst. 2013;18(4):306–15. CrossRef Chen DK, Frizzi KE, Guernsey LS, Ladt K, Mizisin AP, Calcutt NA. Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheralneuropathy in type‑1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst. 2013;18(4):306–15. CrossRef
4.
Zurück zum Zitat Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31(1):96–8. CrossRef Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31(1):96–8. CrossRef
5.
Zurück zum Zitat Shaw JE, Sicree PZ, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. CrossRef Shaw JE, Sicree PZ, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. CrossRef
6.
Zurück zum Zitat Ahmadi A, Hasanzadeh J, Rahimi MM, Lashgari L. Factors affecting the quality of life in patients with type 2 diabetes Chahar Mahal Bakhtiari. J North Khorasan Univ Med Sci. 2011;3(1):7–13. CrossRef Ahmadi A, Hasanzadeh J, Rahimi MM, Lashgari L. Factors affecting the quality of life in patients with type 2 diabetes Chahar Mahal Bakhtiari. J North Khorasan Univ Med Sci. 2011;3(1):7–13. CrossRef
7.
Zurück zum Zitat Rahmanian E, Salari N, Mohammadi M, Jalali R. Evaluation of sexual dysfunction and female sexual dysfunction indicators in women with type 2 diabetes: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:73. CrossRef Rahmanian E, Salari N, Mohammadi M, Jalali R. Evaluation of sexual dysfunction and female sexual dysfunction indicators in women with type 2 diabetes: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:73. CrossRef
8.
Zurück zum Zitat Mohammadi M, Vaisi Raiegani AA, Jalali R, Ghobadi A, Salari N. The prevalence of retinopathy among type 2 diabetic patients in Iran: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2019;20(1):79–88. CrossRef Mohammadi M, Vaisi Raiegani AA, Jalali R, Ghobadi A, Salari N. The prevalence of retinopathy among type 2 diabetic patients in Iran: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2019;20(1):79–88. CrossRef
9.
Zurück zum Zitat Larijani B, Abol Hasani F. Epidemiology of diabetes mellitus in Iran. Iran J Diabetes Lipid Disord. 2001;1(1):1–8. Larijani B, Abol Hasani F. Epidemiology of diabetes mellitus in Iran. Iran J Diabetes Lipid Disord. 2001;1(1):1–8.
10.
Zurück zum Zitat Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J. Potenzial risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005;5:24. CrossRef Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J. Potenzial risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005;5:24. CrossRef
11.
Zurück zum Zitat Hunt D. Using evidence in practice. Foot care in diabetes. Endocrinol Metab Clin North Am. 2002;31:603–11. CrossRef Hunt D. Using evidence in practice. Foot care in diabetes. Endocrinol Metab Clin North Am. 2002;31:603–11. CrossRef
12.
Zurück zum Zitat Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Arch Iran Med. 2013;16(1):17–9. PubMed Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Arch Iran Med. 2013;16(1):17–9. PubMed
13.
Zurück zum Zitat Boulton AJM, Malik RA, Arezz JC, Sosenko JM. Diabetic somatic neuropatheis. Diabetes Care. 2004;27:1458–86. CrossRef Boulton AJM, Malik RA, Arezz JC, Sosenko JM. Diabetic somatic neuropatheis. Diabetes Care. 2004;27:1458–86. CrossRef
14.
Zurück zum Zitat Miralles-García JM, de Pablos-Velasco P, Cabrerizo L, Pérez M, López-Gómez V. Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years’ disease duration. Endocrinol Nutr. 2010;57(9):414–20. CrossRef Miralles-García JM, de Pablos-Velasco P, Cabrerizo L, Pérez M, López-Gómez V. Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years’ disease duration. Endocrinol Nutr. 2010;57(9):414–20. CrossRef
15.
Zurück zum Zitat Abbasian M, Delvarianzadeh M. Evaluation of complications of diabetes in patients referring to diabetes clinic in Shahrood. J Knowl Health. 2007;2(4):17–21. Abbasian M, Delvarianzadeh M. Evaluation of complications of diabetes in patients referring to diabetes clinic in Shahrood. J Knowl Health. 2007;2(4):17–21.
16.
Zurück zum Zitat Mohamadianinejad SE, Shahbazian HB, Kashipazha D, Karimi M, Oghbaei M, Shalilahmadi D, et al. Risk factors associated with diabetic neuropathy in type 2 diabetic patients referred to diabetic clinic of Golestan Hospital, Ahvaz, Iran. Jundishapur Sci Med J. 2013;12(2):141–7. Mohamadianinejad SE, Shahbazian HB, Kashipazha D, Karimi M, Oghbaei M, Shalilahmadi D, et al. Risk factors associated with diabetic neuropathy in type 2 diabetic patients referred to diabetic clinic of Golestan Hospital, Ahvaz, Iran. Jundishapur Sci Med J. 2013;12(2):141–7.
17.
Zurück zum Zitat Khamseh ME, Nakhjavani M, Hossainpanah F, Kalantari S, Sanjari M, Mohammadpeigi M. How to control the metabolic rate and the incidence of diabetes mellitus in patients with type 2 diabetes in Iran. J Payesh. 2013;13(6):705–12. Khamseh ME, Nakhjavani M, Hossainpanah F, Kalantari S, Sanjari M, Mohammadpeigi M. How to control the metabolic rate and the incidence of diabetes mellitus in patients with type 2 diabetes in Iran. J Payesh. 2013;13(6):705–12.
18.
Zurück zum Zitat Kargarian Marvasti S, Abolghasemi J, Heydari I, Rimaz S. Effective factors in the time of development of neuropathy in type II diabetic patients. Iran J Epidemiol. 2017;13(2):80–9. Kargarian Marvasti S, Abolghasemi J, Heydari I, Rimaz S. Effective factors in the time of development of neuropathy in type II diabetic patients. Iran J Epidemiol. 2017;13(2):80–9.
19.
Zurück zum Zitat Khatoni A, Abdi A, Hoseini E, Fattah pour T, Feizi H. Assessment of risk factors and complications of type2 diabetes in patients of Ghasreshirin diabetes center in 2011. Nurs J Vulnerable. 2015;2(2):1–14. Khatoni A, Abdi A, Hoseini E, Fattah pour T, Feizi H. Assessment of risk factors and complications of type2 diabetes in patients of Ghasreshirin diabetes center in 2011. Nurs J Vulnerable. 2015;2(2):1–14.
20.
Zurück zum Zitat Heshmati H, Behnampour N, Khorasani F, Moghadam Z. Prevalence of chronic complications of diabete and its related factors in referred type 2 diabetes patients in Freydonkenar diabetes center. J Neyshabur Univ Med Sci. 2014;1(1):36–34. Heshmati H, Behnampour N, Khorasani F, Moghadam Z. Prevalence of chronic complications of diabete and its related factors in referred type 2 diabetes patients in Freydonkenar diabetes center. J Neyshabur Univ Med Sci. 2014;1(1):36–34.
21.
Zurück zum Zitat Bostani R, Afkhamizadeh M, Shahri B, Ahmadi S. Frequency of diabetic polyneuropathy based on clinical and phlebological findings. Med J Mashhad Univ Med Sci. 2012;55(2):81–7. Bostani R, Afkhamizadeh M, Shahri B, Ahmadi S. Frequency of diabetic polyneuropathy based on clinical and phlebological findings. Med J Mashhad Univ Med Sci. 2012;55(2):81–7.
22.
Zurück zum Zitat Abbaspour S, Shamaeiyan N, Hasanzadeh M, Zandi Z, Sepehri A. Self-care behaviors among diabetic patients referred to a selected hospital clinic in Torbat-e-Heydarieh. Q Torbat Heydarieh Sch Med Sci. 2012;1(1):65–70. Abbaspour S, Shamaeiyan N, Hasanzadeh M, Zandi Z, Sepehri A. Self-care behaviors among diabetic patients referred to a selected hospital clinic in Torbat-e-Heydarieh. Q Torbat Heydarieh Sch Med Sci. 2012;1(1):65–70.
23.
Zurück zum Zitat Azdanpanah P, Ghaffarian Shirazi HR, Hatamipour Y, Shariatinia F, Vafaei F. Prevalence of peripheral neuropathy in patients of type 2 diabetes mellitus in Dena township in 2004. J Armaghan-e-Danesh. 2005;11(1):75–81. Azdanpanah P, Ghaffarian Shirazi HR, Hatamipour Y, Shariatinia F, Vafaei F. Prevalence of peripheral neuropathy in patients of type 2 diabetes mellitus in Dena township in 2004. J Armaghan-e-Danesh. 2005;11(1):75–81.
24.
Zurück zum Zitat Moosavi H, Tahery N, Rabii S, Rohani Manesh F. Prevalence of neuropathy in type II diabetic patients covered by the healthcare center of Ahwaz Petroleum Industry in 2012–2013. J Diabetes Nurs. 2014;2(3):29–37. Moosavi H, Tahery N, Rabii S, Rohani Manesh F. Prevalence of neuropathy in type II diabetic patients covered by the healthcare center of Ahwaz Petroleum Industry in 2012–2013. J Diabetes Nurs. 2014;2(3):29–37.
25.
Zurück zum Zitat Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia. 1998;41:1263–9. CrossRef Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia. 1998;41:1263–9. CrossRef
26.
Zurück zum Zitat Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian first nation community. Diabetes Care. 2008;31:1837–41. CrossRef Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian first nation community. Diabetes Care. 2008;31:1837–41. CrossRef
27.
Zurück zum Zitat Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India. 2002;50:546–50. PubMed Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India. 2002;50:546–50. PubMed
28.
Zurück zum Zitat Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med J Malaysia. 2003;58:533–8. PubMed Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med J Malaysia. 2003;58:533–8. PubMed
29.
Zurück zum Zitat Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonsken PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–4. CrossRef Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonsken PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–4. CrossRef
30.
Zurück zum Zitat Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus: the San Luis Valley diabetes study. Am J Epidemiol. 1990;131:633–43. CrossRef Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus: the San Luis Valley diabetes study. Am J Epidemiol. 1990;131:633–43. CrossRef
31.
Zurück zum Zitat Dyck PJ, Katz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24. CrossRef Dyck PJ, Katz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24. CrossRef
32.
Zurück zum Zitat Nabavi NM, Ahmed A, Bril V, Orszag A, Ng E, Nwe P, et al. Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes. PLoS One. 2012;7940:e34807. CrossRef Nabavi NM, Ahmed A, Bril V, Orszag A, Ng E, Nwe P, et al. Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes. PLoS One. 2012;7940:e34807. CrossRef
33.
Zurück zum Zitat Sung JY, Park SB, Liu YT, Kwai N, Arnold R, Krishnan AV, et al. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes. 2012;61(6):1592–8. CrossRef Sung JY, Park SB, Liu YT, Kwai N, Arnold R, Krishnan AV, et al. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes. 2012;61(6):1592–8. CrossRef
34.
Zurück zum Zitat Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, et al. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea. Diabet Med. 2012;29(9):e290–e6. CrossRef Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, et al. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea. Diabet Med. 2012;29(9):e290–e6. CrossRef
35.
Zurück zum Zitat Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–50. CrossRef Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–50. CrossRef
36.
Zurück zum Zitat Oguejiofor OC, Odenigbo CU, Oguejiofor CB. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry. Niger J Clin Pract. 2010;13(3):240–7. PubMed Oguejiofor OC, Odenigbo CU, Oguejiofor CB. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry. Niger J Clin Pract. 2010;13(3):240–7. PubMed
37.
Zurück zum Zitat Franse LV, Valk GD, Dekker JH, Heine RJ, van Eijk JTM. Numbness of the feet is a  poor indicator for polyneuropathy in type 2 diabetic patients. Diabet Med. 2000;17:105–10. CrossRef Franse LV, Valk GD, Dekker JH, Heine RJ, van Eijk JTM. Numbness of the feet is a  poor indicator for polyneuropathy in type 2 diabetic patients. Diabet Med. 2000;17:105–10. CrossRef
38.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32(Suppl 1):S13–S61. CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32(Suppl 1):S13–S61. CrossRef
Metadaten
Titel
Prevalence of neuropathy in patients with type 2 diabetes in Iran
A systematic review and meta-analysis
verfasst von
MD Dariush Afshari Aliabadi
MD Nasrin Moradian
MSc Elham Rahmanian
MSc Masoud Mohammadi
Publikationsdatum
17.12.2020
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 5-6/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-020-01784-w